ZTS

NYSE

Zoetis Inc.

Health Care, Pharmaceuticals

$72.66

close 7 Aug 2026

-51.24%

52-week change

$30.09B

market cap

$71.47

$160.48

52-week range

Expected price

$191.07 – $233.53

Current price

$72.66

Signal

Could be undervalued

A historical-multiple reference, never a fair-value claim. The band uses only data public at each date and ends at the latest month — no forward estimates.

Current multiples

P/E (TTM)11.87x

P/S (TTM)3.16x

P/B9.56x

EV/EBITDA (TTM)9.37x

FCF yield (TTM)7.70%

PEG (TTM, GAAP)1.16

Context

P/E, own 5-year average33.61x

P/E, sector median29.65x*

Price at 5-year median P/E$215.20*

Indicated dividend yield2.92%

Forward — analyst consensus

Forward P/E (FY2026)11.25x*

Forward P/E (FY2027)10.28x

Forward PEG1.20*

Consensus EPS FY2026 (10 analysts)$6.46

EPS growth (FY2026→FY2027)9.37%

Revenue growth (FY2026)0.70%

Street view

Price target (mean)$108.38*

Target upside49.15%

Ratings (buy / hold / sell)10 / 9 / 0

FY2026 EPS revisions, 30d (up / down)0 / 6

5-year history

Dashed line: average of month-end values

P/E (TTM)

P/S (TTM)

P/B

FCF yield (TTM)

Dividend yield

period to 30 Jun 2026, filed 6 Aug 2026, close 7 Aug 2026

Discounted cash flow

Ten projected years plus a perpetuity, prefilled from filings — a model to argue with, never a fair-value claim.

Free cash flow, last ten years and TTM

5Y CAGR +6.41%10Y CAGR +17.90%

Assumptions

Growth rate, years 1–10%

Perpetual growth%Discount rate%

Base FCF$M

As filed — not assumptions

Current price$72.66

Cash & equivalents$1.48B

Total debt$9.05B

Shares outstanding414.15M

Result

DCF price per share$123.16

Current price$72.66

Margin of safety+69.50%

PV of years 1–10$21.37B

PV of terminal value$37.21B

Equity value$51.01B

Market-implied growth+0.75%

Projected FCF, years 1–10

Hover for PV and growth

Projection detail

Override growth for any year; blank years use the uniform rate

Year	2026	2027	2028	2029	2030	2031	2032	2033	2034	2035	Terminal
Growth, %											2.5
FCF	$2.46B	$2.62B	$2.79B	$2.97B	$3.16B	$3.36B	$3.58B	$3.81B	$4.05B	$4.31B	$80.34B
PV	$2.28B	$2.25B	$2.22B	$2.18B	$2.15B	$2.12B	$2.09B	$2.06B	$2.03B	$2.00B	$37.21B

period to 30 Jun 2026, filed 6 Aug 2026, close 7 Aug 2026